Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.
about
Psychological factors predict adherence to methotrexate in rheumatoid arthritis; findings from a systematic review of rates, predictors and associations with patient-reported and clinical outcomesRefill rates of accessories for positive airway pressure therapy as a surrogate measure of long-term adherenceFolic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritisEffectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry.Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis.Models solely using claims-based administrative data are poor predictors of rheumatoid arthritis disease activityIdentification of risk factors for elevated transaminases in methotrexate users through an electronic health record.Folic Acid Supplementation Is Suboptimal in a National Cohort of Older Veterans Receiving Low Dose Oral Methotrexate.A Multistakeholder Approach to Improving Quality in Rheumatoid Arthritis: Proceedings from the Rheumatoid Arthritis Quality Expert Medical Panel.Predictors of longterm changes in body mass index in rheumatoid arthritis.Weight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis.Adherence to Methotrexate therapy in Rheumatoid Arthritis.Agreement between Rheumatologist and Patient-reported Adherence to Methotrexate in a US Rheumatoid Arthritis Registry.Utilization of Care Outside the Veterans Affairs Health Care System by US Veterans With Rheumatoid Arthritis.Racial and ethnic disparities in rheumatoid arthritis.Non-persistence and non-adherence to MTX therapy in patients with rheumatoid arthritis: a retrospective cohort study based on German RA patients.Influence of route of administration/drug formulation and other factors on adherence to treatment in rheumatoid arthritis (pain related) and dyslipidemia (non-pain related).Treating rheumatoid arthritis to target: physician and patient adherence issues in contemporary rheumatoid arthritis therapy.The use of natural language processing on narrative medication schedules to compute average weekly dose.Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis.Changes in Body Mass Related to the Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis.Optimisation of a treat-to-target approach in rheumatoid arthritis: strategies for the 3-month time point.Medication adherence has an impact on disease activity in rheumatoid arthritis: a systematic review and meta-analysis.Disease characteristics and treatment patterns in veterans with rheumatoid arthritis and concomitant hepatitis C infection.Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity.Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis.Factors associated with methotrexate dosing and therapeutic decisions in veterans with rheumatoid arthritis.Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study.Adherence to combination DMARD therapy and treatment outcomes in rheumatoid arthritis: a longitudinal study of new and existing DMARD users.
P2860
Q26768683-562AA58E-9813-4551-9118-A0EF3142D1B3Q28382807-38976D97-FD02-4D83-9C64-19016843CDB6Q28394552-3B6D062D-EC6A-4091-BDCB-B8ACF5BA87F5Q30940329-5A5F6534-8BBB-4ED5-A4F3-BFA4E37204B5Q33551313-E538EB8A-FFBA-4E17-B58E-83449C6BE19DQ33651231-21608CC7-A2A0-465B-8ECF-AD8DC2BE27CBQ33955217-31270F36-72E8-4C79-97B7-CFD1431FEB92Q36225180-769D4BC7-0F2F-4D44-8D10-3D90FC66E368Q36266374-ECA797E3-259B-4946-BF63-9913A1DB4D4DQ36784187-BF841F74-366D-438B-86FE-E94692162EF8Q36784192-CEB578DC-DEDD-4704-87BF-53378AFF6B47Q36876445-BE288012-1C53-46AB-B617-3954AA049CCBQ36963533-3C74E43C-E5DF-431C-92CB-8EDFC0E3582FQ37733448-F4FFE31A-3747-4CC7-8B76-FF5BD33544EAQ38024756-42BD2130-7018-4E23-9074-012F3E04EA8FQ38633143-7BD50441-4F64-4B4A-8343-156688EEE887Q38867559-3B2E13E0-9F45-422B-A5B9-E25251EB2310Q38960132-065C05E9-68E3-4DB3-A317-3F23E42B8348Q39385266-A6AF9374-F9C7-4CBA-878E-9A2594108294Q39702204-86241DE1-B01F-44BA-B893-0775894D9332Q39993473-0E3572A0-71B4-4A1E-8877-09EA6C44FFBCQ40484774-236A2C06-FB66-4E86-949A-28CBB597102BQ41359106-8DE28E9A-CC18-461A-90B3-6F1E3D7F0E21Q41754920-85188225-CDC7-48BD-80AF-BFFF32B259DEQ43867998-38A5E6BE-10ED-4292-B922-F9E0234F7F4DQ45012451-A71B6F47-BEAC-426A-AC3B-355A4C713BA5Q45329356-461ECE94-4908-49CD-A2F3-CA50CF9940C3Q50198473-6DCD0528-8817-4677-BDBD-D1876E99F211Q53122503-8FD0588C-02A7-43F7-B603-F04143F549AE
P2860
Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Merging Veterans Affairs rheum ...... activity in clinical practice.
@ast
Merging Veterans Affairs rheum ...... activity in clinical practice.
@en
type
label
Merging Veterans Affairs rheum ...... activity in clinical practice.
@ast
Merging Veterans Affairs rheum ...... activity in clinical practice.
@en
prefLabel
Merging Veterans Affairs rheum ...... activity in clinical practice.
@ast
Merging Veterans Affairs rheum ...... activity in clinical practice.
@en
P2093
P2860
P356
P1476
Merging Veterans Affairs rheum ...... activity in clinical practice
@en
P2093
Andreas M Reimold
Candace L Hayden
Dannette S Johnson
Gail S Kerr
Grant W Cannon
J Steuart Richards
Jeffrey R Curtis
Liron Caplan
Ted R Mikuls
P2860
P304
P356
10.1002/ACR.20629
P577
2011-12-01T00:00:00Z